Although no publications explicitly link NPTX2 methylation to lung cancer development, it has been reported that NPTX2 functions as a tumor suppressor in various solid cancers, such as pancreatic cancer, prostate cancer, glioblastoma, and thymic epithelial tumors. Here, NPTX2 is linked to familial pancreatic carcinoma.